The most common EGFR-TKI–related adverse events were dermatitis acneiform and paronychia, whereas the most common anti-angiogenesis–related adverse events were proteinuria (21.7%) and hypertension (18.3%). The gene discussed is EGFR; the disease is Hypertension.